Eg. Levin et al., LIPOPROTEINS INHIBIT THE SECRETION OF TISSUE-PLASMINOGEN ACTIVATOR FROM HUMAN ENDOTHELIAL-CELLS, Arteriosclerosis and thrombosis, 14(3), 1994, pp. 438-442
We studied the effect of lipoprotein(a) [Lp(a)], low-density lipoprote
in (LDL), and high-density lipoprotein (HDL) on tissue plasminogen act
ivator (TPA) secretion from human endothelial cells. At 1 mu mol/L, Lp
(a) inhibited constitutive TPA secretion by 50% and phorbol myristate
acetate- and histamine-enhanced TPA secretion by 40%. LDL and HDL also
depressed TPA secretion by 45% and 35% (constitutive) and 40% to 60%
(stimulated). TPA mRNA levels were also examined and found to change i
n parallel with antigen secretion. In contrast to TPA, plasminogen act
ivator inhibitor type-1 secretion and mRNA levels were not affected by
any of the three lipoproteins. These results suggest that the interac
tion of lipoproteins with certain cell-surface binding sites may inter
fere with the proper production and/or secretion of TPA. (Arterioscler
Thromb. 1993;14:438-442.)